Shardul Amarchand Mangaldas & Co. (“SAM”) advised a consortium of lenders led by Canara Bank, and comprising Canara Bank, Punjab & Sind Bank and Bank of Baroda, in relation to the resolution of the debt of Karanja Terminal & Logistics Private Limited (“KTLPL”), through the transfer of the lenders’ entire loan exposure to Prudent ARC… Read More +

Shardul Amarchand Mangaldas & Co. (“SAM”) advised Eloquent Info Solutions Private Limited, operating the technology-driven recruitment platform WorkIndia, in connection with its USD 10.8 million Series B investment round.   WorkIndia operates in the HR technology space, focusing on large-scale, technology-enabled recruitment solutions for India’s blue and grey-collar workforce. The investment is expected to support… Read More +

Shardul Amarchand Mangaldas & Co. (“SAM”) advised a consortium of NCD investors and a working capital lender on a twin financing of INR 2,300 crore to Jayaswal Neco Industries Limited. The NCD investors include Tata Capital Limited, Investec, DSP Finance Private Limited, Nippon India Credit Opportunities AIF, Piramal Finance Limited, Vivriti Funds, Hero FinCorp Limited,… Read More +

Shardul Amarchand Mangaldas & Co. (“SAM”) advised Aica Kogyo Company, Limited (Japan) (“Aica”) on its USD 225 million (approximately) acquisition of a controlling stake of upto 53.12% in Stylam Industries Limited (“Stylam”), involving secondary purchases from existing promoters and a mandatory open offer to public shareholders under the SEBI Takeover Regulations.   SAM advised Aica on the… Read More +

Shardul Amarchand Mangaldas & Co. (“SAM”) acted as legal counsel to Biocon Limited on its ₹4,150 crore (approximately USD 460 million) Qualified Institutions Placement (“QIP”) of equity shares.   The QIP was undertaken in pursuance of Biocon’s strategy to fully integrate its subsidiary, Biocon Biologics Limited by combining businesses, and witnessed participation from leading institutional… Read More +